Meyka Pro banner
Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. (DN.TO) Stock Overview

Explore Delta 9 Cannabis Inc.’s financial performance, market position, analyst ratings, and future outlook.

DN.TOTSX
HealthcareDrug Manufacturers - Specialty & Generic
$0.005
$0.005(50.00%)
Canadian Market opens in 16h 43m

Delta 9 Cannabis Inc. (DN.TO)

Meyka AI Score

Z

Key Financials

Market Cap1.5M
P/E Ratio-0.05
EPS (TTM)$-0.10
ROE48.99%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

DN.TO Stock Analysis & Investment Overview (TSX)

Our AI-powered analysis of Delta 9 Cannabis Inc. (TSX: DN.TO) gives investors deep insight into how the stock performs on the TSX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Delta 9 Cannabis Inc.'s TSX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of DN.TO on the TSX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the TSX listing.

Key metrics behind Delta 9 Cannabis Inc.'s TSX-traded stock include a P/E ratio of -0.05 and a market capitalization of 1.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of DN.TO on the TSX.

Price Performance (TSX: DN.TO)

1-Day Change
N/A
5-Day Change
-50.00%
1-Month Change
-50.00%
3-Month Change
-83.33%
6-Month Change
-75.00%
Year-to-Date (YTD) Change
-80.00%
1-Year Change
-91.67%
3-Year Change
-98.81%
5-Year Change
-99.49%
All-Time (Max) Change
-99.78%

Contact Information

855-245-1259
P.O. Box 68096, Winnipeg, MB, R3L 2V9

Company Facts

2,000 Employees
IPO DateNov 6, 2017
CountryCA

Frequently Asked Questions